Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

A Study of Indinavir Taken With or Without DMP 266

ClinicalTrials.gov ID: NCT00002393

Public ClinicalTrials.gov record NCT00002393. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 24, 2026, 3:59 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III, Double-Blind, Placebo-Controlled, Multicenter Study to Determine the Effectiveness and Tolerability of the Combination of DMP 266 and Indinavir Versus Indinavir in HIV-Infected Patients Receiving Nucleoside Analogue (NRTI) Therapy

Study identification

NCT ID
NCT00002393
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Dupont Merck
Industry
Enrollment
300 participants

Conditions and interventions

Conditions

Interventions

  • Indinavir sulfate Drug
  • Efavirenz Drug

Drug

Eligibility (public fields only)

Age range
13 Years to 60 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Not listed
Primary completion
Not listed
Completion
Not listed
Last update posted
Jun 23, 2005

United States locations

U.S. sites
9
U.S. states
8
U.S. cities
9
Facility City State ZIP Site status
Kaiser Foundation Hospital San Francisco California 94118
Med College of Georgia Augusta Georgia 30912
Chicago Ctr for Clinical Research Chicago Illinois 60610
Univ of Kentucky Med Ctr / Chandler Med Ctr Lexington Kentucky 405360084
Tulane Univ / Tulane / LSU Clinical Trials Unit New Orleans Louisiana 70122
Mount Sinai Med Ctr New York New York 10029
Univ of Rochester Med Ctr Rochester New York 14642
Vanderbilt Univ Nashville Tennessee 372321302
Hampton Roads Med Specialists Hampton Virginia 23666

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00002393, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 23, 2005 · Synced Jul 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00002393 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →